|
ZNF701 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.791800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.193600E-01 |
| Normal-vs-Stage2 |
4.119400E-01 |
| Normal-vs-Stage3 |
1.278580E-01 |
| Normal-vs-Stage4 |
9.001600E-01 |
| Stage1-vs-Stage2 |
7.746400E-01 |
| Stage1-vs-Stage3 |
6.016900E-03 |
| Stage1-vs-Stage4 |
4.173800E-01 |
| Stage2-vs-Stage3 |
4.502300E-02 |
| Stage2-vs-Stage4 |
4.006800E-01 |
| Stage3-vs-Stage4 |
2.483600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.882600E-01 |
| Normal-vs-AfricanAmerican |
4.007800E-02 |
| Normal-vs-Asian |
4.966200E-02 |
| Caucasian-vs-AfricanAmerican |
1.243790E-02 |
| Caucasian-vs-Asian |
1.412950E-01 |
| AfricanAmerican-vs-Asian |
1.637890E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.804000E-01 |
| Normal-vs-Female |
5.616600E-01 |
| Male-vs-Female |
1.389160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.403200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.446000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.084000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.188800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.219600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.595400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.346400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.566200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.281190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.897200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.313570E-01 |
| Normal-vs-Grade 2 |
4.411000E-01 |
| Normal-vs-Grade 3 |
7.995800E-01 |
| Normal-vs-Grade 4 |
2.008800E-01 |
| Grade 1-vs-Grade 2 |
2.928600E-01 |
| Grade 1-vs-Grade 3 |
1.861600E-01 |
| Grade 1-vs-Grade 4 |
8.056100E-02 |
| Grade 2-vs-Grade 3 |
2.316000E-01 |
| Grade 2-vs-Grade 4 |
2.870100E-02 |
| Grade 3-vs-Grade 4 |
2.376200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.858800E-01 |
| Normal-vs-ccB subtype |
6.565200E-01 |
| ccA subtype-vs-ccB subtype |
4.928000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.541600E-01 |
| Normal-vs-N1 |
7.437600E-01 |
| N0-vs-N1 |
4.602400E-01 |
|
|
